SCHEMBL4040280

SCHEMBL4040280

CC(C)(C)OC(=O)N1CCC(NC(=O)OCc2ccccc2)C1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
CPB1 P15086 2/20 0.47
CTSL P07711 2/20 0.44
CTSB P07858 1/20 0.44
CTSK P43235 1/20 0.44
AGTR2 P50052 1/20 0.44
TSHR P16473 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ABCB1 P08183 1/20 0.43
HTT P42858 1/20 0.43
PDE4B Q07343 1/20 0.42
KLK7 P49862 1/20 0.42
STS P08842 1/20 0.42
SYK P43405 1/20 0.42
PREP P48147 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14468657 1.00 ALDH1A1 (0.47) ALDH1A1GAACPB1CTSLCTSB
SCHEMBL5941341 1.00 ALDH1A1 (0.47) ALDH1A1GAACPB1CTSLCTSB
SCHEMBL31058400 1.00 ALDH1A1 (0.47) ALDH1A1GAACPB1CTSLCTSB
SCHEMBL18337377 0.93 CPB1 (0.48) ALDH1A1GAACPB1CTSLCTSB
SCHEMBL32672364 0.92 CPB1 (0.53) ALDH1A1GAACPB1CTSLCTSB
SCHEMBL25907340 0.92 CPB1 (0.53) ALDH1A1GAACPB1CTSLCTSB
SCHEMBL6347376 0.90 CPB1 (0.46) ALDH1A1GAACPB1CTSLCTSB
SCHEMBL18335958 0.90 CPB1 (0.46) ALDH1A1GAACPB1CTSLCTSB
SCHEMBL18337016 0.89 CPB1 (0.45) ALDH1A1GAACPB1CTSLTSHR
SCHEMBL18337160 0.89 CPB1 (0.45) ALDH1A1GAACPB1CTSLTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1771170-A4 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2009-07-08 EP disclosed
EP-1601673-B1 FUSED HETEROCYCLES AND USES THEREOF ASTRAZENECA AB (SE) 2009-06-10 EP disclosed
EP-1546150-B1 PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES AMURA THERAPEUTICS LTD (GB) 2009-03-04 EP disclosed
EP-1771170-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2007-04-11 EP disclosed
WO-2006020003-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2006-02-23 WO disclosed
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP disclosed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO disclosed